Conference Coverage

Caring for Children With Seizures Who Use Cannabinoids


 

References

If it’s appropriate, families can enroll their children in an observational research study. Families can also consider participating in pharmaceutical double-blind, placebo-controlled trials. Other practical tips include standardizing the way neurologists care for children who use cannabinoids in their practice, and working in advance with hospital administrators and the inpatient pharmacy to address the use of these products for inpatients.

A 2014 Cochrane review concluded that “no reliable conclusions can be drawn at present regarding the efficacy of cannabinoids as a treatment for epilepsy,” Dr. Brooks-Kayal said. A systematic review by the American Academy of Neurology reached the same conclusion. The American Epilepsy Society, the American Academy of Pediatrics, and the American Medical Association do not recommend routine clinical use of cannabinoids for seizures, but call for additional research. “We need better data,” Dr. Brooks-Kayal said.

Kari Oakes

Pages

Recommended Reading

Cannabinoids for seizures: Frankness, comfort, and follow-up are key to gathering data
MDedge Neurology
FDA: CT scans safe for patients with electronic medical devices
MDedge Neurology
Fetal malformation risk not increased after exposure to lamotrigine
MDedge Neurology
Once-Daily Eslicarbazepine May Prevent Seizures as Well as Twice-Daily Carbamazepine
MDedge Neurology
Pregnancy Considerations for Women With Epilepsy—The WEPOD Study
MDedge Neurology
Women with epilepsy conceive at normal rate
MDedge Neurology
Once-daily eslicarbazepine equals twice-daily carbamazepine for controlling partial-onset seizures
MDedge Neurology
Ilo Leppik, MD
MDedge Neurology
Lamotrigine May Not Increase Fetal Malformation Risk
MDedge Neurology
Physicians and Patients Lack a Common Understanding of Seizure Clusters
MDedge Neurology

Related Articles